Share

IIR document

Injectable cryogel microcarriers for cell transplantation and growth factor delivery.

Number: pap. 011

Author(s) : WELZEL P. B., NEWLAND B., NEWLAND H., et al.

Summary

Biohybrid cryogel microcarriers comprised of heparin and four-arm poly(ethylene glycol) (starPEG) were synthesized by combining an emulsion technique with cryogelation processing. Freezing the gelling reaction mixture whilst dispersed in an organic solvent at -20 °C or -40 °C followed by lyophilisation gave rise to micron scale hydrogel particles with interconnected macropores, which could be loaded with various cell types. Due to their spongy structure and their dense pore walls the microcarriers could be injected through a 27 gauge needle without a negative effect on the cell viability. The artificial 3D cell microenvironment provided by the macropores could be further enhanced by covalent attachment of adhesion ligands. The highly negative charge of heparin allowed for strong binding of growth factors and their sustained release. Consequently, this microcarrier platform creates exiting new options for combination therapies, e.g. for the treatment of neurodegenerative diseases or for therapeutic vascularization.

Available documents

Format PDF

Pages: 4 p.

Available

  • Public price

    20 €

  • Member price*

    Free

* Best rate depending on membership category (see the detailed benefits of individual and corporate memberships).

Details

  • Original title: Injectable cryogel microcarriers for cell transplantation and growth factor delivery.
  • Record ID : 30019500
  • Languages: English
  • Source: 2nd IIR Workshop on cold applications in life sciences.
  • Publication date: 2016/09/08
  • DOI: http://dx.doi.org/10.18462/iir.cals.2016.0011

Links


See other articles from the proceedings (25)
See the conference proceedings

Indexing